Squarepoint’s Zosano Pharma Corporation ZSAN Stock Holding History

Squarepoint’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-532	Closed	-$23K	–	3950
2021 Q1	$23K	Buy	+532	New	+$22.3K	﹤0.01%	3027
2020 Q4	–	Sell	-768	Closed	-$44K	–	3399
2020 Q3	$44K	Buy	+768	New	+$35.8K	﹤0.01%	2380
2018 Q2	–	Sell	-2,524	Closed	-$445K	–	2164
2018 Q1	$445K	Buy	+2,524	New	+$844K	0.01%	1132

Other funds holding ZSAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Squarepoint's ZSAN Position: Q2 2021 in Review

Squarepoint sold out of Zosano Pharma Corporation (ZSAN) in Q2 2021, closing a stake of 532 shares — an estimated $23K sold.

Squarepoint first reported a position in ZSAN in Q1 2018 and held it in 3 quarters. The position peaked at $445K in Q1 2018. 34 funds tracked by Wall St. Rank hold ZSAN as of Q2 2021.

Squarepoint reported no remaining Zosano Pharma Corporation position as of Q2 2021 after selling out during the quarter.
Squarepoint sold 532 Zosano Pharma Corporation shares in Q2 2021, an estimated $23K.
Squarepoint first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 3 quarters.
Squarepoint's Zosano Pharma Corporation position peaked at $445K in Q1 2018.
34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.